Clearside Biomedical, Inc. — Director's Dealing 2024

Apr 19, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Clearside Biomedical, Inc. (CLSD)
CIK: 0001539029
Period of Report: 2024-04-17

Reporting Person: Gibney Anthony S (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-04-17	Common Stock	P	6710	$1.25	Acquired	6710	Direct
2024-04-18	Common Stock	P	93290	$1.30	Acquired	100000	Direct

Footnotes

F1: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.249 to $1.38 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.